Betty Z. Benedict Endowment of $2 Million to SCTC:

SCTC - Scleroderma Clinical Trials Consortium

Our Misson

The Scleroderma Clinical Trial Consortium advances standards of research for people with scleroderma by conducting, sponsoring, and facilitating projects that improve clinical outcomes with a special focus on clinical trials.

Detailed Version:
The SCTC is an international consortium representing the majority of researchers and clinicians who have particular interest and expertise in the care of, and research in, scleroderma (systemic sclerosis).  The goal of the SCTC is to conduct, sponsor, or facilitate clinical research projects that lead to advances in the management, treatment, and outcomes of patients with scleroderma.  The SCTC represents the views and interests of its membership regarding the performance of clinical research in scleroderma.  The SCTC seeks to ensure that research in scleroderma adheres to high standards for design, conduct, and reporting of results.  The SCTC is particularly focused on improving and developing outcome measures for clinical trials and observational studies, participating in the design and conduct of clinical trials and observational studies, and helping to improve the efficiency of clinical trials.  The SCTC strongly encourages international collaboration, inclusiveness in research groups, and involvement of trainees and junior faculty in all its activities.


Upcoming Meetings

SCTC's Annual General Meeting 2023 - Live!

November 11th, 2023 in San Diego

Invitation to the entire SCTC membership, as well as our Industry Roundtable members, to join us for our in-person annual general meeting!
More details to come!

Find out about the SCTC Benedict Visiting Fellowship Programme

The 2023 Request for Funds Application for the SCTC and SRF sponsored Betty Z. Benedict Grant is now available!

The 2023 Request for Grant Applications for the SCTC Working Groups is now closed.

Congratulations to the Betty Z. Benedict Grant winners of 2022!
Dinesh Khanna and Alain Lescoat

This grant is co-sponsored by the Scleroderma Research Foundation.

Congratulations to the SCTC 2022 Working Group Grant Winners!

Get Involved with SCTC

2021 Betty Z. Benedict Grant for Proposals to Advance the Science of Outcome Measures in Systemic Sclerosis

Become a Member of SCTC

Please join us. There are two types of Membership to choose from:

>> Full member

>> Provisional Member

Donate to SCTC

Donate today to help SCTC and its mission to support research to establish standard outcome measures for clinical treatment trials so that results can be compared over time and over different patient groups.

Pay Membership Fees

If you are a newly accepted member of the SCTC, please select Initial Fee at $250.00 USD.
If you are a returning member of the SCTC, please select the option of Annual Fee at $200.00 USD.
If your institution is unable to use PayPal, please contact

Membership Fees

© 2023 Scleroderma Clinical Trials Consortium. Designed By Kangablu Ltd